treatment

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago

SSRI Discontinuation Syndrome

By: Shannon Tellier, PharmD Candidate c/o 2013 - Antidepressant discontinuation syndrome has been reported in all categories of antidepressants after…

14 years ago

Ivacaftor (KalydecoTM): Targeting the Core of Cystic Fibrosis

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…

14 years ago

Low-dose SSRIs for the Overly Sensitive Esophagus

By Sunhae Chang, PharmD Candidate c/o 2013 - When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux…

14 years ago

Duloxetine’s Effect on Blood Glucose Levels

By: Neal Shah, Co-Editor-in-Chief - Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US…

14 years ago

NYS Legislature to Ban Selling Tobacco Products in Pharmacies

By: Mahdieh Danesh Yazdi - The views expressed in this article are solely those of the author and do not…

14 years ago

The Role of NMDA in Electroconvulsive Therapy and Other Neuropsychological Disorders

By: Neal Shah, Co-Editor-in-Chief - Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other…

14 years ago

Medications Causing Body Temperature Fluctuations

By: Elsa Thomas, Pharm.D. c/o 2013 - Human body uses various complex mechanisms to maintain its body temperature within a…

14 years ago

My Experiences at NewYork-Presbyterian Hospital

By: Addolorata Ciccone, Student Copy Editor - As a fifth-year pharmacy student researching and ranking advanced pharmacy practice experience (APPE)…

14 years ago

Influenza Vaccines: Projected Strains for the 2012—2013 Season

By: Joo Hee Kwon, Pharm.D. Candidate c/o 2013 - There are 3 antigenic types of influenza: A, B, and C.…

14 years ago

Bisphosphonates and Atypical Fracture Risk

By: Steve Soman, Pharm.D. Candidate c/o 2013 - Bisphosphonates are proven to enhance bone density and reduce fracture incidence in…

14 years ago

Antiplatelet Use Following Acute Coronary Syndromes

By: Addolorata Ciccone, Co-Copy Editor - Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction…

14 years ago

Brand Vs. Generic: What Every Prescriber Should Know

By: Marina Yermolayeva, PharmD Candidate c/o 2013 - “I’m allergic to the generic; I need the brand name medication,” is…

14 years ago

Nutrition Support Pharmacy Practice

By: James W. Schurr, PharmD Candidate c/o 2014 - Nutrition Support Pharmacy is a specialized practice pertaining to the needs…

14 years ago

Quick Update: Triptan Pharmacology

By: Neal Shah, Co-Editor-In-Chief - Migraines can be “classic” or “common.”  While all migraines feature unilateral, pulsating headaches, classic migraines…

14 years ago

Meet the new Beta 3 Agonist: Mirabegron (Myrbetriq®)

By: Steve P. Soman - Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily…

14 years ago

Use of Donepezil in Patients with Delirium (but without Dementia)

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Donepezil, brand name Aricept®, is an acetylcholinesterase inhibitor indicated as monotherapy…

14 years ago

Artificial Saliva Agents in Xerostomia

By: Neal Shah, Co-Editor-in-Chief - Xerostomia, commonly known as dry mouth, is an anti-muscarinic side effect of numerous medications.  Antidepressants,…

14 years ago

Understanding Diabetic Ketoacidosis

By: Mohamed Dungersi, Associate Student Editor -  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…

14 years ago

The Pathophysiology of Syndeham’s Chorea

By: Neal Shah, Co Editor-In-Chief - Dyskinesias are abnormal, involuntary movement disorders.  Subsets of dyskinesias include choreas and atheosis.  Chorea…

14 years ago

The Pathology of Pure Red Cell Aplasia

By: Neal Shah, Co Editor-In-Chief - Pure Red Cell Aplasia (PRCA), also known as erythroblastopenia, is characterized by a suppression…

14 years ago

The Challenges of Pediatric Clinical Drug Trials and Drug Product Labeling

By: Shannon Tellier, Associate Student Editor - The disease burden in children outweighs the number of pediatric clinical drug trials…

14 years ago

A Reflection of my Palliative Care Rotation

By: Stanley Saji, Pharm.D. Candidate c/o 2013 - I had a preconceived notion that advanced pharmacy practice experiences (APPEs) were…

14 years ago

Effect of Intravenous Ondansetron on QT Interval Prolongation

By: Raymond Wu, Pharm.D. Candidate c/o 2013   The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used…

14 years ago

Transplantation in HIV +/- HBV/HCV Patients

By: Jayoung Park, Pharm.D. Candidate c/o 2013 - Traditionally, human immunodeficiency virus (HIV)-infected patients have generally been excluded from organ…

14 years ago

Risk versus Benefit: Prescription to Over the Counter Medications

By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 -   Maria Sorbera was the 2011-2012 President of the Rho Chi…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Proton Pump Inhibitor Use and Complications

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 - We see proton pump inhibitors (PPIs) used in many medication regimens, but…

14 years ago

Role of Calcium Channel Blockers and Beta Blockers in CHF

By: Lunbao Huang Pharm D. Candidate c/o 2013 - The seventh report of the Joint National Committee on high blood…

14 years ago

Lipid Panels: Fasting or Non-Fasting?

By: Nagma Gargi, Pharm D. Candidate 2013 - Traditionally, lipid panels are drawn under fasting conditions. Is there data supporting…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

Interview with: Mr. Phil Hecken, Director of Communications to Sen. Kemp Hannon & Mr. Timothy Broschardt, Legislative Aide to Sen. Kemp Hannon

By: Mahdieh Danesh Yazdi - In previous issues, we discussed prescription drug abuse and several bills currently on the floor…

14 years ago

Counterfeit Prescription Medications: A Global Threat

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Counterfeit prescription medications are becoming a great concern for us. They…

14 years ago

Improving Patient and Health System Outcomes through Advanced Pharmacy Practice

By: Shannon Tellier - In December 2011, a report written to the United States (U.S.) Surgeon General, Dr. Regina Benjamin,…

14 years ago

The Diagnosis and Management of Bipolar Disorder in Children and Adolescents

By: Marie Huang - The amphitheater at Nassau University Medical Center fills up slowly as Dr. Alan Jay Cohen, a…

14 years ago

Drug Shortage Update: FDA Successfully Alleviates Chemotherapy Shortage

By: Mahdieh Danesh Yazdi - As previously reported, there is currently great concern in the medical community because of the…

14 years ago

Jentadueto Approved by FDA for Type 2 Diabetes Mellitus

By: Ebey P. Soman - The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the…

14 years ago

FDA Makes Label Changes to Statins

By: Mohamed Dungersi - On February 28, the U.S. Food and Drug Administration (FDA) approved important safety label changes for…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago

Brilinta® vs. Plavix® in Patients with Acute Coronary Syndromes

By: Ronik Saha, Pharm.D. Candidate c/o 2013 - Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects…

14 years ago

Proton Pump Inhibitors and the Treatment of Osteoporosis

By: Neal Shah - Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces…

14 years ago

Pharmacists Are Healthcare Providers!

By: Sandra Leal Pharm.D., CDE -  Sandra Leal, PharmD, CDE is the Director of Clinical Pharmacy at El Rio Health…

14 years ago

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago

Hope on the Horizon: Chikungunya Vaccine Trial Begins!

By: Ebey P. Soman - Since its discovery in Tanganyika (modern day Mozambique and Tanzania in Africa) in 1952, Chikungunya…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

Liposomal Doxorubicin For Liver Cancer

By Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Over the last two decades, there has been an increasing focus…

14 years ago

FDA Approves Edarbyclor®

By: Gokul Kalla, Pharm.D. Candidate c/o 2013 - Hypertension is a chronic disease that affects one out of every three…

14 years ago

Clevidipine in the Management of Hypertensive Emergency

By: Neal Shah - Defined by the Joint National Committee, hypertension (HTN) is a systolic blood pressure (SBP) greater than…

14 years ago

Greater Bone Loss in Post-Menopausal Women with HIV

By: Bibin Thomas, Long Island University, PharmD Candidate - Earlier in 2011, it was reported that that young and middle-aged…

14 years ago

Alumni Spotlight: Making the Right Decisions

By: Jim Fitzgerald, RPh - James Fitzgerald is a SUNY Buffalo School of Pharmacy graduate from the class of 1980.…

14 years ago